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Abstract The C4-hydroxylation of dihydrosphingosine or dihy-
droceramide is a key reaction in the biosynthesis of phytosphin-
golipids, both in yeasts and in mammalian cells. Mouse DES2
(mDES2) was recently cloned and shown to work as a v4-de-
saturase/C4-hydroxylase, when expressed in yeast cells. Here,
we cloned a human homologue of mDES2, hDES2, by homol-
ogy search utilizing a BLAST program. When expressed in
HEK 293 cells, hDES2 exhibited hydroxylase activity for di-
hydroceramide. Northern blot analyses of hDES2 revealed high
expression in skin, intestines, and kidney, sites reportedly pos-
sessing high levels of phytosphingolipids. Furthermore, up-regu-
lation of hDES2 mRNA expression and subsequent phytocer-
amide production were observed during vitamin C/serum-induced
di¡erentiation of human keratinocytes. These results suggest
that the newly cloned hDES2 plays an essential role in phyto-
sphingolipid synthesis in human skin and other phytosphingo-
lipid-containing tissues.
4 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Sphingolipids are essential components of the plasma mem-
branes of eukaryotic cells, especially within lipid microdo-
mains or rafts [1]. Additionally, sphingolipid metabolites, in-
cluding ceramide, sphingosine, and sphingosine 1-phosphate,
play important roles in diverse biological phenomena, such as
cell growth, di¡erentiation, apoptosis, and stress responses, in
both mammalian and yeast cells [2^4].
Sphingolipids in the yeast Saccharomyces cerevisiae contain
mainly phytosphingosine as a sphingoid base, such as that
synthesized from dihydrosphingosine by C4-hydroxylase, a
product of the SUR2 gene [5,6]. In contrast, the major sphin-
goid bases of mammalian cells are sphingosine and dihydro-
sphingosine. However, some mammalian cells, speci¢cally
those in skin, intestines, and kidney, have been shown to
contain a considerable amount of phytosphingosine-based
sphingolipids [7^9]. Until recently, it had been unclear
whether these are derived from food or from de novo syn-
thesis. However, the mouse DES2 (mDES2) gene was recently
cloned and expressed in vsur2 yeast mutants, and its product
was identi¢ed as sphingolipid v4-desaturase/C4-hydroxylase
[10]. Since then, mDES2 expressed in COS7 cells has also
been found to exhibit C4-hydroxylase activity [11].
In this study, we have cloned the human homologue of
DES2 (hDES2), using the BLAST program with the Gen-
Bank1 human EST data base, and have demonstrated that
hDES2 expressed in HEK 293 cells exhibits C4-hydroxylation
activity. Northern blotting analyses of hDES2 revealed high
expression in skin, intestines, and kidney, sites previously re-
ported as having high levels of phytosphingolipids. We have
also examined roles for hDES2 during vitamin C/serum-in-
duced di¡erentiation of human primary keratinocytes.
2. Materials and methods
2.1. Cell culture and transfection
HEK 293 cells were grown in Dulbecco’s modi¢ed Eagle’s medium
containing 10% fetal calf serum, in a humidi¢ed atmosphere of 5%
CO2 at 37‡C. Cells were transfected with the indicated cDNA using
LipofectAMINE Plus (Invitrogen, Carlsbad, CA, USA), according to
the manufacturer’s manual. Lysates of transiently transfected cells
were prepared 24 h after transfection.
Normal human epidermal keratinocytes, isolated from neonatal
skin, were obtained from Cambrex (MD, USA). Primary cultures
were maintained in a serum-free keratinocyte growth medium (Gibco,
Grand Island, NY, USA), containing 0.07 mM calcium, and grown to
90^100% con£uence. Keratinocyte di¡erentiation was performed as
described previously [12] using di¡erentiation medium, a mixture of
Dulbecco’s modi¢ed Eagle’s medium and Ham F-12 medium (2:1,
v/v), supplemented with 1.3 mM calcium, 10% fetal bovine serum,
10 Wg/ml insulin, 0.4 Wg/ml hydrocortisone, and 50 Wg/ml vitamin C.
2.2. Plasmid construction
The hDES2 cDNA was ampli¢ed by reverse transcription polymer-
ase chain reaction (RT-PCR) using human epidermal keratinocyte
total RNA and the primers 5P-ACCATGGGCAACAGCGCGA-
GCCGC-3P and 5P-GCTCACAGACCATCTTTTGCCAGC-3P. The
ampli¢ed DNA fragment was cloned into pGEM-T Easy vector
(Promega, Madison, WI, USA) to generate pGEM-hDES2. The ob-
tained nucleotide sequence has been deposited with GenBank1 with
the accession number AY541700.
pCE-puro-3UFLAG, a derivative of pCE-puro [13], was con-
structed to create a C-terminally triple FLAG (3UFLAG)-tagged
gene. BamHI sites were created at both the 5P- and 3P-termini of
hDES2 by PCR ampli¢cation using primers 5P-GGGATCCACC-
ATGGGCAACAGCGCGAGCCGC-3P and 5P-GGGATCCGACA-
GACCATCTTTTGCCAGCC-3P from the pGEM-hDES2. The am-
pli¢ed 0.98 kb fragment was digested with BamHI and cloned into
the BamHI site of the pCE-puro-3UFLAG to generate pCE-puro-
hDES2-3UFLAG. pcDNA3-hDES2 was constructed by cloning 1.0
kb EcoRI fragments from pGEM-hDES2 into the EcoRI sites of
pcDNA3 (Invitrogen).
2.3. In vitro dihydroceramide hydroxylase assay
In vitro dihydroceramide hydroxylase assays were performed essen-
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tially as described previously [14], with minor modi¢cations. Brie£y,
cells suspended in lysis bu¡er (50 mM HEPES^NaOH (pH 7.5) con-
taining a 1Uprotease inhibitor mixture (Complete1, Roche Molecu-
lar Biochemicals)) were lysed by sonication. Total cell lysates (0.5 mg
protein) were mixed with 3.0 nmol N-octanoyl-D-erythro-dihydro-
sphingosine (Biomol, Plymouth Meeting, PA, USA) and 0.5 WCi
[4,5-3H]N-octanoyl-D-erythro-dihydrosphingosine (40 Ci/mmol, Amer-
ican Radiolabeled Chemicals, St. Louis, MO, USA), diluted with 50
mM HEPES bu¡er (pH 7.5) to a volume of 300 Wl, and treated with
octyl-L-glucoside (¢nal concentration 0.3%). After a preincubation of
5 min at 37‡C, the reaction was started by the addition of NADPH
(¢nal concentration 5 mM), followed by incubation for 1 h at 37‡C.
Lipids were then extracted as described previously [14] and separated
by thin layer chromatography (TLC) on silica gel 60 plates (Merck),
coated with sodium borate, using chloroform/methanol/water
(80:10:1, v/v).
2.4. Immunoblotting
Immunoblotting was performed as described previously [15] using
the anti-FLAG antibody, M2 (Sigma, St. Louis, MO, USA).
2.5. Methanolysis
The reagent for lipid methanolysis was prepared by diluting 0.86 ml
of concentrated HCl and 0.94 ml of water to methanol (¢nal volume
10 ml) [16]. After lipids were reacted with 0.5 ml reagent at 70‡C for
20 h, samples were mixed with 0.25 ml of 2 N NaOH and 0.5 ml
chloroform. After centrifuging the sample at 1500Ug for 5 min the
lower phase was collected. The extraction step was repeated twice.
The combined organic phase was then washed with distilled water
to remove NaOH. Once dried, the lipids were suspended in 20 Wl
chloroform/methanol (1:2, v/v) and resolved by TLC on Silica Gel
60 high performance TLC plates (HPTLC, Merck) with chloroform/
methanol/4.2 N ammonia (15:3.8:0.8, v/v).
2.6. [3H]Dihydrosphingosine labeling assay
Cells were metabolically labeled with 2.0 WCi [4,5-3H]D-erythro-di-
hydrosphingosine (50 Ci/mmol, American Radiolabeled Chemicals).
After incubating at 37‡C for 24 h, the cells were washed with phos-
phate-bu¡ered saline, followed by lipid extraction as described previ-
ously [17]. The labeled lipids were separated on HPTLC plates using
chloroform/methanol/acetic acid (190:9:1, v/v). After drying, the
HPTLC plates were developed again with the same solvent system.
2.7. Northern blot analysis
Analysis was performed on total RNA blots containing 20 Wg of
RNA from adult human tissues (RNWAY Laboratories, Korea). The
hDES2 probe was prepared from a DNA fragment, corresponding to
the N-terminal 500 bp of the hDES2 ORF, which was ampli¢ed from
pGEM-hDES2 using the primers 5P-CCATGGGCAACAGCGCG-
AGCCGC-3P and 5P-GCGGGTGTGCAGAAGAACCAGC-3P. The
ampli¢ed fragment was then labeled with [32P]dCTP using a Random
Primer DNA labeling Kit (Takara, Shiga, Japan). Hybridization was
carried out in ExpressHyb bu¡er (Clontech, Palo Alto, CA, USA) for
5 h at 68‡C.
2.8. RT-PCR
Total RNA was isolated from human epidermal keratinocytes using
Trizol reagent (Invitrogen). RT-PCR was performed using a Super-
Script One-Step RT-PCR with Platinum Taq kit (Invitrogen). Primers
used were as follows: hDES1, 5P- CCATGGGGAGCCGCGTCTCG-
CG-3P and 5P-TGAAAGCGGTACAGAAGAACCAGC-3P ; hDES2,
5P-ACACCCGCCCGCAAGCTGCTCTG-3P and 5P-TGCCAGCCT-
GTACACCCGCTTC-3P ; keratin 1, 5P-GGTGGACGTGGTAGTG-
GCTTTG-3P and 5P-TTCAGTTCCGAATCCAACCGAG-3P ; and
L-actin, 5P-TGATGATATCGCCGCGCTCGTCGTC-3P and 5P-GC-
ATACCCCTCGTAGATGGGCACAG-3P.
3. Results
3.1. Identi¢cation of hDES2
A previous study identi¢ed mDES1, mDES2, and hDES1
as mammalian DES family members and characterized their
sphingolipid v4-desaturase/C4-hydroxylase activities by ex-
pression in S. cerevisiae [10]. However, cloning and character-
ization of hDES2 have not been reported. To identify the
hDES2 cDNA, the GenBank1 human EST data base was
searched using the BLAST program, for sequences similar
Fig. 1. Comparison of the amino acid sequences of human and mouse DES1 and DES2. An alignment of amino acid sequences from hDES1
(GenBank1 accession number AF466375), mDES1 (AF466376), hDES2 (AY541700), and mDES2 (AF466376) was generated using ClustalW
[32] and BOXSHADE (Institute for Animal Health, Surrey, UK) programs. The black boxes indicate identical residues, and the gray boxes
show amino acid similarity. Putative transmembrane segments (TM1^TM3) predicted by the SOSUI program (http://sosui.proteome.bio.tuat.
ac.jp) are underlined. The histidine box motifs are enclosed by boxes.
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to the mDES2 sequence. We found several EST clones, in-
cluding CA488047, BQ129385 and CA314430, which exhib-
ited high sequence similarity to mDES2, although they con-
tain only partial but overlapping sequences. By assembling
these sequences, we were able to predict an entire open read-
ing frame (ORF), subsequently named hDES2. Based on this
nucleotide sequence, we performed an RT-PCR using total
RNA from human epidermal keratinocytes and obtained
cDNA for the hDES2 ORF. The ORF of hDES2 encodes
323 amino acids with a predicted molecular mass of 37.2
kDa (Fig. 1). Since hDES2 is highly homologous to mDES2
throughout the entire sequence (86.4% identity and 91.9%
similarity), it is most likely a counterpart of mDES2.
The DES family members illustrated in Fig. 1 belong to the
desaturase/hydroxylase superfamily, which is characterized by
the existence of three conserved histidine boxes, HX34H,
HX23HH, and HX23HH, designated Ia, Ib, and IIa, respec-
tively [18]. However, although DES1 members (mDES1 and
hDES1) and DES2 members (mDES2 and hDES2) exhibit
similarity overall (in amino acid sequence, polypeptide length,
and hydropathy pro¢le), certain amino acids are conserved
only in the DES2 members. One of the most striking di¡er-
ences between DES1 and DES2 members is a variation in the
second amino acid residue of each histidine box. Whereas
DES1 members contain Glu, Met and Asn at that position
in Ia, Ib, and IIa, respectively, DES2 members have Asp, Val,
and Val/Met. Another characteristic feature of DES2 mem-
bers is the existence of an additional HX23HH motif desig-
nated IIb.
3.2. hDES2 exhibits dihydroceramide hydroxylase activity
HEK 293 cells were transiently transfected with pCE-puro-
hDES2-3UFLAG encoding the C-terminally 3UFLAG-
tagged hDES2 (hDES2-FLAG). Immunoblots using an anti-
FLAG antibody detected hDES2-3UFLAG as a 35 kDa band
(Fig. 2A). This mobility was slightly faster than the predicted
molecular mass of 41.2 kDa.
To investigate the dihydroceramide hydroxylase activity of
hDES2, an in vitro assay was performed using [3H]dihydro-
ceramide (N-octanoyl dihydrosphingosine) as a substrate. Cell
lysates prepared from HEK 293 cells transfected with a con-
trol vector plasmid e¡ectively converted dihydroceramide to
ceramide (corresponding to N-nonhydroxyacyl sphingosine
(Cer-NS)) (Fig. 2B). On the other hand, only a very low
amount of phytoceramide (corresponding to N-nonhydroxy-
acyl phytosphingosine (Cer-NP)) was detected. These results
indicate that HEK 293 cells possess high dihydroceramide
desaturase activity, whereas the hydroxylase activity is very
weak.
Overexpression of hDES2-3UFLAG in HEK 293 cells had
no e¡ect on the amount of ceramide produced but resulted in
a marked increase in phytoceramide production (Fig. 2B).
Methanolysis of the ceramide and phytoceramide generated
sphingosine and phytosphingosine, respectively (Fig. 2C),
which co-migrated with cold sphingosine and phytosphingo-
sine standards (data not shown).
We next investigated the hydroxylase activity of hDES2 in
cultured cells by [3H]dihydrosphingosine labeling assay. HEK
293 cells transfected with control vector plasmid produced
two bands corresponding to long-chain ceramide/dihydrocer-
amide and short-chain ceramide/dihydroceramide, but no
phytoceramide (Fig. 3). On the other hand, HEK 293 cells
overexpressing hDES2 did produce phytoceramide (Fig. 3).
These results provide evidence that hDES2 functions as a
dihydroceramide hydroxylase.
3.3. Tissue distribution of hDES2 mRNA expression
We examined the tissue distribution pattern of hDES2 by
Northern blotting. Hybridization of the hDES2 probe to total
RNA from 12 di¡erent tissues detected a 1.8 kb band in brain,
lung, kidney, large intestine, small intestine, and skin (Fig. 4).
The expression level was the highest in skin. We could not
detect transcription in heart, liver, spleen, skeletal muscle,
Fig. 2. hDES2 is a dihydroceramide hydroxylase. A: HEK 293 cells
were transfected with pCE-puro-3UFLAG (vector, lane 1) and
pCE-puro-hDES2-3UFLAG (lane 2). Total cell lysates (25 Wg pro-
tein) were subjected to immunoblotting using an anti-FLAG anti-
body. B: Total lysates (0.5 mg protein) prepared from HEK 293
cells transfected with pCE-puro-3UFLAG (lane 2) or with pCE-
puro-hDES2-3UFLAG (lane 3) were incubated with [3H]N-octanoyl
dihydrosphingosine at 37‡C for 60 min. Lipids were extracted and
separated by TLC on borate-coated silica plates. Lane 1, [3H]N-oc-
tanoyl dihydrosphingosine substrate. C: TLC lipid spots were recov-
ered from B, and ceramide (lane 1) and phytoceramide (lane 2)
were subjected to methanol-HCl hydrolysis and resolved by
HPTLC.
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thymus or placenta. Thus, in contrast to hDES1 mRNA,
which is expressed ubiquitously [19], distribution of hDES2
mRNA appears to be highly tissue-speci¢c.
3.4. hDES2 mRNA expression during keratinocyte
di¡erentiation
Correlating with the high expression of hDES2 mRNA,
skin contains a large amount of phytosphingosine-based
sphingolipids. Previous studies have demonstrated that,
upon di¡erentiation, keratinocytes produce heterogeneous
ceramides, including phytoceramides (Cer-NP and N-K-hy-
droxyacyl phytosphingosine (Cer-AP)) [12,20]. We examined
whether expression of hDES2 mRNA was regulated during in
vitro keratinocyte di¡erentiation, using RT-PCR. Di¡erentia-
tion of normal human keratinocytes was induced by vitamin
C and serum. Normal progression of the di¡erentiation was
veri¢ed by monitoring the synthesis of ceramides character-
istic to epidermis, including Cer-NP and Cer-AP (Fig. 5A)
[12], as well as by the mRNA expression of keratin 1, a
marker for terminal di¡erentiation of keratinocytes [21]
(Fig. 5B). hDES2 mRNA was not expressed at day 0 or
3 days after di¡erentiation (Fig. 5B). At day 6, DES2 tran-
scription was detected, increasing by day 9 (Fig. 5B). On the
other hand, the expression levels of hDES1 and L-actin
mRNAs did not change throughout the keratinocyte di¡er-
entiation (Fig. 5B).
4. Discussion
Mammalian cells, speci¢cally those in skin, intestines, and
kidney, have long been known to contain phytosphingosine-
based sphingolipids [7^9], although it was unclear whether
these were derived from food or synthesized locally. In recent
studies, forced expression of the mouse DES2 protein in the
vsur2 yeast mutants restored the C4-hydroxylase activity [10].
Furthermore, results presented here (Fig. 2B) and recent stud-
ies using mouse DES2 [11] have demonstrated that mamma-
lian DES2 expressed in cultured cells exhibits in vitro dihy-
droceramide hydroxylase activity. We also revealed that
overexpression of hDES2 results in the production of phyto-
ceramide in cultured cells (Fig. 3). Thus, mammals have the
potential to synthesize phytosphingosine-based sphingolipids.
The distribution of phyto-type sphingolipids correlates well
with the expression pattern of DES2. For example, tissue-
speci¢c expression of DES2 was observed in tissues containing
phyto-type sphingolipids. Recently, high levels of mDES2
mRNA were observed in small intestine and kidney using
an RT-PCR method, although skin was not examined [11].
Here, we demonstrated by Northern blot analysis that hDES2
is highly expressed in skin, small and large intestines, and
kidney. Additionally, synthesis of phyto-type sphingolipids
correlated with the appearance of hDES2 mRNA during
keratinocyte di¡erentiation. Finally, a decrease in mDES2
mRNA in cultured keratinocytes from mice lacking ARNT
(transcription factor of the Per/AHR/ARNT/Sim family)
Fig. 4. Tissue-speci¢c expression of hDES2 mRNA. A 32P-labeled
hDES2 probe was hybridized to total RNA from 12 di¡erent hu-
man tissues (20 Wg/lane). Lane 1, brain; lane 2, heart; lane 3, lung;
lane 4, liver; lane 5, spleen; lane 6, kidney; lane 7, large intestine;
lane 8, small intestine; lane 9, skeletal muscle; lane 10, thymus;
lane 11, skin; lane 12, placenta.
Fig. 5. Expression of hDES2 mRNA is induced in keratinocyte dif-
ferentiation. A: Undi¡erentiated keratinocytes (lane 1) or those dif-
ferentiated for 9 days (lane 2) were labeled with [3H]dihydro-
sphingosine for 24 h at 37‡C. Lipids were extracted and separated
by HPTLC. Cer 1, N-(O-linoleoyl) g-hydroxyacyl sphingosine; Cer
2, Cer-NS; Cer 3, Cer-NP; Cer 4, N-(O-linoleoyl) g-hydroxyacyl
6-hydroxysphingosine; Cer 5, N-K-hydroxyacyl sphingosine; Cer 6,
Cer-AP; Cer 7, N-K-hydroxyacyl 6-hydroxysphingosine. B: Kerati-
nocytes were di¡erentiated for 0, 3, 6, and 9 days. mRNAs prepared
at each time point were subjected to RT-PCR using primers for
hDES1, hDES2, keratin 1, and L-actin.
Fig. 3. Overexpression of hDES2 increases phytoceramide in cul-
tured cells. HEK 293 cells transfected with pcDNA3 (vector, lane 1)
or pcDNA3-hDES2 (lane 2) were labeled with [3H]dihydrosphin-
gosine for 24 h. Lipids were extracted and separated by HPTLC.
Note that ceramide and dihydroceramide could not be separated by
the solvent system used.
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was accompanied by a decrease in phytoceramide level [22].
Such correlation supports the hypothesis that phyto-type
sphingolipids are synthesized in mammals by DES2, especially
in light of an in vivo study in rats which detected radiolabeled
phytosphingosine in the intestine and kidneys following an
intravenous injection of [3H]dihydrosphingosine [23].
When expressed in yeast, mDES2 exhibits both desaturase
and hydroxylase activity. However, no desaturase activity was
detected following expression of hDES2 in cultured cells (Fig.
2B). It is not clear whether, in mammalian cells, DES2 pos-
sesses only hydroxylase activity or whether the desaturase
activity is masked by a high background activity. In contrast,
DES1 exhibits only desaturase activity, despite sharing high
sequence similarity with DES2 [10,11].
Substitutions of four key residues in the Arabidopsis thali-
ana oleate desaturase or the Lesquerella fendleri hydroxylase/
desaturase, members of the same desaturase/hydroxylase fam-
ily as DES1 and DES2, in£uenced the partitioning of the ca-
talysis between desaturation and hydroxylation [24,25]. How-
ever, the equivalent residues in DES1 and DES2 are identical.
This suggests that these residues are not important in the
determination of catalytic partitioning in the DES family
members. In contrast, some di¡erences were found between
DES1 and DES2 members, such as a disparity in the second
residue of each histidine box motif (Ia, Ib, and IIa). More-
over, only DES2 members contain an additional histidine box
motif, termed IIb. The yeast Scs7p, which exhibits sphingo-
lipid K-hydroxylase but not desaturase activity [18], also pos-
sesses this additional motif, suggesting that the motif is im-
portant for the hydroxylase activity.
The function of phyto-type sphingolipids in skin remains
unclear. However, the levels of these lipids are altered in sev-
eral skin diseases displaying epidermal barrier abnormalities.
Psoriasis is a hyperproliferative disease of the epidermis char-
acterized by a defective skin barrier function. In psoriatic
skin, the phytosphingosine-carrying ceramides (Cer-NP and
Cer-AP) are signi¢cantly decreased [26]. Additionally, levels
of N-(O-linoleoyl) g-hydroxyacyl dihydrosphingosine, as well
as those of Cer-NP, were low in patients with atopic derma-
titis [27]. Moreover, the quantity of Cer-NP can be signi¢-
cantly correlated with transepidermal water loss [28]. Thus,
it is possible that phyto-type sphingolipids play an important
barrier function in skin.
In addition to its role as a component of certain sphingo-
lipids, phytosphingosine can function as a bioactive lipid mol-
ecule via its conversion to phytosphingosine 1-phosphate.
Edg6/S1P4, which is speci¢cally expressed in lymphoid tissue
[29], shows a high a⁄nity to phytosphingosine 1-phosphate
[30]. When overproduced in CHO cells, Edg6/S1P4 stimulated
motility via activation of Cdc42 [31]. Recently, we detected
kinase activity against phytosphingosine in certain tissues (in-
cluding small intestine), which di¡ered from that of already
known sphingosine kinases (SPHK1 and SPHK2) [15]. Future
studies of DES2 may provide clues towards elucidating the
physiological functions of both phyto-type sphingolipids and
phytosphingosine 1-phosphate.
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